CLINICAL_TRIALS
trial_result
· 2014-10-15
Clinical Trial Update: Ranolazine Monotherapy in Subjects With Type 2 Diabetes Mellitus [Phase 3]
Summary
Phase 3 trial evaluating ranolazine as a monotherapy in adults with type 2 diabetes mellitus; the study has completed and results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Gilead Sciences | Conditions: Type 2 Diabetes Mellitus | Phase 3 | Status: COMPLETED | Results posted: 2014-10-15